Daniel Parera

Partner, Kurma Partners

Daniel Parera is a physician-entrepreneur turned investor, bringing hands-on clinical and operational founder experience to growth-stage life sciences investing. He focuses on later-stage European biotech companies, drawing on his own background as an operator to evaluate and support businesses moving from proof of concept toward commercial scale.

Based in Munich, Daniel plays a connecting role between the German-speaking biotech ecosystem and the broader European life sciences investment landscape. He has particular expertise in radiopharmaceuticals and oncology, reflected in his board involvement with companies in that space, including his role at Nuclidium following a major growth financing round.